111
Views
20
CrossRef citations to date
0
Altmetric
Original

INTRAPLEURAL LOW-MOLECULAR-WEIGHT UROKINASE OR TISSUE PLASMINOGEN ACTIVATOR VERSUS SINGLE-CHAIN UROKINASE IN TETRACYCLINE-INDUCED PLEURAL LOCULATION IN RABBITS

, , , , , , , , & show all
Pages 419-440 | Received 26 Jul 2007, Accepted 31 Aug 2007, Published online: 02 Jul 2009

REFERENCES

  • Colice GL, Curtis A, Deslauriers J, Heffner J, Light R, Littenberg B, Sahn S, Weinstein RA, Yusen RD: Medical and surgical treatment of parapneumonic effusions. AACP Consensus Statement. Chest. 2000;18:1158–1171.
  • Sonnappa S, Cohen G, Owens CM, van Doorn C, Cairns J, Stanojevic S, Elliott MJ, Jaffe A: Comparison of urokinase and video-assisted thoracoscopic surgery for treatment of childhood empyema. Am J Respir Crit Care Med. 2006;174:221–227.
  • Maskell NA, Davies CW, Nunn AJ, Hedley EL, Gleeson FV, Miller R, Gabe R, Rees GL, Peto TE, Woodhead MA, Lane DJ, Darbyshire JH, Davies RJ: U.K. controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med. 2005;352:865–874.
  • Light RW: Parapneumonic effusions and empyema. Proc Am Thorac Soc. 2006;3:75–80.
  • Bouros D, Schiza S, Siafakas N: Utility of fibrinolytic agents for draining intrapleural infections. Semin Respir Infect. 1999;14:39–47.
  • Bouros D, Schiza S, Tzanakis N, Chalkiadakis G, Drositis J, Siafakas N: Intrapleural urokinase versus normal saline in the treatment of complicated parapneumonic effusions and empyema. A randomized, double-blind study. Am J Respir Crit Care Med. 1999;159:37–42.
  • Bouros D, Schiza S, Patsourakis G, Chalkiadakis G, Panagou P, Siafakas NM: Intrapleural streptokinase versus urokinase in the treatment of complicated parapneumonic effusions: a prospective, double-blind study. Am J Respir Crit Care Med. 1997;155:291–295.
  • Bouros D, Schiza S, Tzanakis N, Drositis J, Siafakas N: Intrapleural urokinase in the treatment of complicated parapneumonic pleural effusions and empyema. Eur Respir J. 1996;9:1656–1659.
  • Idell S, Mazar A, Cines D, Kuo A, Parry G, Gawlak S, Juarez J, Koenig K, Azghani A, Hadden W, McLarty J, Miller E: Single-chain urokinase alone or complexed to its receptor in tetracycline-induced pleuritis in rabbits. Am J Respir Crit Care Med. 2002;166:920–926.
  • Idell S, Allen T, Chen S, Koenig K, Mazar A, Azghani A: Intrapleural activation, processing, efficacy and duration of protection of single chain urokinase in evolvingtetracycline-induced pleural injury in rabbits. Am J Physiol Lung Cell Mol Physiol. 2007;192:L25–L32.
  • Idell S, Girard W, Koenig KB, McLarty J, Fair DS: Abnormalities of pathways of fibrin turnover in the human pleural space. Am Rev Respir Dis. 1991;144:187–194.
  • Philip-Joet F, Alessi MC, Philip-Joet C, Aillaud M, Barriere JR, Arnaud A, Juhan-Vague I: Fibrinolytic and inflammatory processes in pleural effusions. Eur Respir J. 1995;8:1352–1356.
  • Miller EJ, Kajikawa O, Pueblitz S, Light RW, Koenig KK, Idell S: Chemokine involvement in tetracycline-induced pleuritis. Eur Respir J. 1999;14:1387–1393.
  • Idell S: Endothelium and disordered fibrin turnover in the injured lung: newly recognized pathways. Crit Care Med. 2002;30:S274–S280.
  • Strange C, Baumann MH, Sahn SA, Idell S: Effects of intrapleural heparin or urokinase on the extent of tetracycline-induced pleural disease. Am J Respir Crit Care Med. 1995;151:508–515.
  • Idell S, Pendurthi U, Pueblitz S, Koenig K, Williams T, Rao LV: Tissue factor pathway inhibitor in tetracycline-induced pleuritis in rabbits. Thrombosis Haemostasis. 1998;79:649–655.
  • Heffner JE. Multicenter trials of treatment for empyema—after all these years. N Engl J Med. 2005;352:926–928.
  • Cameron R, Davies HR: Intra-pleural fibrinolytic therapy versus conservative management in the treatment of parapneumonic effusions and empyema. Cochrane Database Syst Rev. 2004; CD002312.
  • Tokuda Y, Matsushima D, Stein GH, Miyagi S: Intrapleural fibrinolytic agents for empyema and complicated parapneumonic effusions: a meta-analysis. Chest. 2006;129:783–790.
  • Bdeir K, Muciano J-C, Tomaszewski J, Koniares L, Martinez J, Cines DB: Urokinase contributes to fibrinolysis in the pulmonary microcirculation. Blood. 2000;96:1820–1826.
  • Tuncozgur B, Ustunsoy H, Sivrikoz MC, Dikensoy O, Topal M, Sanli M, Elbeyli L: Intrapleural urokinase in the management of parapneumonic empyema: a randomised controlled trial. Int J Clin Pract. 2001;55:658–660.
  • Tillett WS, Sherry S: The effect in patients of streptococcal fibrinolysin (streptokinase) and streptococcal desoxyribonuclease on fibrinous, purulent and sanguinous pleural exudations. J Clin Invest. 1949;28:173–190.
  • Light RW: Hemothorax. In: Pleural Diseases, 4th ed. Philadelphia: Lippincott Williams and Wilkins; 2001:320–326.
  • Behrendt N, List K, Andreasen PA, Dano K: The pro-urokinase plasminogen-activation system in the presence of serpin-type inhibitors and the urokinase receptor: rescue of activity through reciprocal pro-enzyme activation. Biochem J. 2003;371:277–287.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.